Bank Pictet & Cie Europe AG Has $148.38 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Bank Pictet & Cie Europe AG increased its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 1.8% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 253,783 shares of the healthcare conglomerate's stock after purchasing an additional 4,432 shares during the period. UnitedHealth Group accounts for 3.5% of Bank Pictet & Cie Europe AG's portfolio, making the stock its 6th largest holding. Bank Pictet & Cie Europe AG's holdings in UnitedHealth Group were worth $148,382,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. lifted its position in UnitedHealth Group by 0.6% during the 1st quarter. Vanguard Group Inc. now owns 84,405,255 shares of the healthcare conglomerate's stock valued at $41,755,280,000 after purchasing an additional 544,740 shares during the period. Price T Rowe Associates Inc. MD grew its holdings in UnitedHealth Group by 0.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 26,062,928 shares of the healthcare conglomerate's stock worth $12,893,331,000 after acquiring an additional 94,641 shares during the period. Bank of New York Mellon Corp lifted its stake in shares of UnitedHealth Group by 0.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate's stock valued at $4,094,247,000 after purchasing an additional 35,533 shares during the period. Dimensional Fund Advisors LP grew its stake in shares of UnitedHealth Group by 30.0% during the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate's stock worth $1,942,956,000 after purchasing an additional 880,183 shares during the period. Finally, Ameriprise Financial Inc. lifted its stake in UnitedHealth Group by 0.6% in the second quarter. Ameriprise Financial Inc. now owns 3,772,487 shares of the healthcare conglomerate's stock valued at $1,920,039,000 after buying an additional 21,149 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

NYSE:UNH opened at $569.98 on Wednesday. The stock has a market capitalization of $526.33 billion, a PE ratio of 37.13, a P/E/G ratio of 1.67 and a beta of 0.58. The company has a current ratio of 0.91, a quick ratio of 0.88 and a debt-to-equity ratio of 0.74. The firm has a fifty day simple moving average of $584.46 and a 200 day simple moving average of $536.30. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $608.63.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. UnitedHealth Group's revenue was up 9.2% on a year-over-year basis. During the same period last year, the business posted $6.56 EPS. On average, research analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were issued a $2.10 dividend. The ex-dividend date was Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.47%. UnitedHealth Group's dividend payout ratio is currently 54.72%.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on UNH shares. Stephens cut their price target on shares of UnitedHealth Group from $632.00 to $605.00 and set an "overweight" rating on the stock in a research report on Wednesday, October 16th. KeyCorp began coverage on shares of UnitedHealth Group in a report on Friday, October 11th. They issued an "overweight" rating and a $675.00 price target for the company. StockNews.com raised UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Wednesday, October 16th. HSBC downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Thursday, October 17th. Finally, Robert W. Baird raised their price objective on shares of UnitedHealth Group from $597.00 to $640.00 and gave the stock an "outperform" rating in a report on Wednesday, July 17th. Three research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.